Particle.news
Neurology Cancer Treatment Drug Development Gene Therapy Neuroscience Innovative Treatments Immunotherapy Animal Studies Therapies Gene Therapy Trials Autoimmune Diseases Preclinical Models Drug Efficacy Drug Approval Data Annotation Phase 3 Trials Patient Outcomes Gene Editing Pain Management Spinal Cord Injury Vaccine Development Treatment Efficacy Cardiovascular Diseases Preclinical Studies Cancer Treatments Osteoarthritis Phase 3 Studies Genetic Disorders Device Development Blood Tests Experimental Treatments Cancer Research FDA Approval Dietary Interventions Neurological Disorders Human Studies Obesity Treatments YouScreen Trial Transplantation Trials Idiopathic Pulmonary Fibrosis Protein Analysis Preventive Medicine Therapeutic Efficacy Respiratory Failure Treatments Amputation Estrogen Therapy Patient Care Funding Challenges Liver Disease Prenatal Treatment Sensitivity and Specificity Infectious Diseases Research Institutions Heart Disease Drug Effectiveness Surgical Techniques Evidence-Based Medicine Organ Donation Animal Models Long-COVID Treatments Brain Implants Patient Recruitment Challenge Trials Male Contraception Trials Allergies Regulatory Compliance Groundbreaking Research Diabetes Medications Treatment Prediction Fatigue Disorders Diabetes Study Findings Inflammation Research Animal Testing Adaptive Treatments Drug Repurposing Stem Cell Therapy Weight-loss Studies PD-1 Immunotherapy Survival Rates Research Methodology Organ Transplantation Human Trials Parkinson's Drug IVF Technology Desensitization Therapy Dietary Studies Neurosurgery Ovarian Function In Vitro Studies Pilot Studies Gender Bias Safety Testing Patient Studies Cannabis Research Data Security Targeted Therapy Obesity Treatment Motor Neurone Disease Neurodegenerative Diseases
The Nature Materials study reports week-long, tumor-localized IL-12 delivery that overcame immunotherapy resistance in metastatic models.
